Federated Hermes’s Kalaris Therapeutics KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.69K Hold
2025
Q1
$5.09K Buy
2024
Q4
$5.55K Hold
2024
Q3
$10.7K Sell
2024
Q2
$11K Buy
2024
Q1
$11.5K Buy
2023
Q4
$1.34K Buy
2022
Q3
Sell
2022
Q2
$1K Sell
2022
Q1
$860K Buy